
Waldenstrom Macroglobulinemia: Innovation Heats Up as Next-Gen Therapies Challenge the BTK Standard | CI Insights
Waldenstrom Macroglobulinemia sees growing innovation as next-gen BTK inhibitors and novel therapies aim to overcome resistance and reshape treatment pathways. AUSTIN, TX, UNITED STATES, June 23, 2025 /EINPresswire.com/ -- Waldenstrom …